A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells

Stem Cells International

Volumn 2014, Issue , 2014, Pages

  Gao, Qing ^a   Guo, Maojuan ^a   Jiang, Xijuan ^a   Hu, Xiantong ^a   Wang, Yijing ^a   Fan, Yingchang ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; AZACITIDINE; BETA CATENIN; CONNEXIN 43; GLYCOGEN SYNTHASE KINASE 3BETA; MYOCYTE ENHANCER FACTOR 2; PROTEIN MEF 2C; SALVIANOLIC ACID B; TROPONIN T; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; IMMUNOFLUORESCENCE TEST; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84904135831     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2014/162024     Document Type: Article

References (36)

1. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J. I., Umezawa A., Ogawa S., Cardiomyocytes can be generated from marrow stromal cells in vitro. Journal of Clinical Investigation 1999 103 5 697 705 2-s2.0-0033106384 (Pubitemid 29122423)
2. Fukuda K., Yuasa S., Stem cells as a source of regenerative cardiomyocytes. Circulation Research 2006 98 8 1002 1013 2-s2.0-33646789159 10.1161/01.RES.0000218272.18669.6e
3. Wang T., Xu Z., Jiang W., Ma A., Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. International Journal of Cardiology 2006 109 1 74 81 2-s2.0-33645410509 10.1016/j.ijcard.2005.05.072
4. Liu X. N., Yin Q., Zhang H., Zhang H., Zhu S. J., Wei Y. J., Hu S. S., Tissue extracts from infarcted myocardium of rats in promoting the differentiation of bone marrow stromal cells into cardiomyocyte-like cells. Biomedical and Environmental Sciences 2008 21 2 110 117 2-s2.0-43949136429 10.1016/S0895-3988(08)60015-X (Pubitemid 351702401)
5. Xing Y., Lv A., Wang L., Yan X., The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Molecular and Cellular Biochemistry 2012 360 1-2 279 287 2-s2.0-83555176083 10.1007/s11010-011-1067-z
6. Kanno S., Kim P. K. M., Sallam K., Lei J., Billiar T. R., Shears L. L. II, Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2004 101 33 12277 12281 2-s2.0-4344647981 10.1073/pnas.0401557101 (Pubitemid 39145434)
7. Rebelatto C. K., Aguiar A. M., Senegaglia A. C., Aita C. M., Hansen P., Barchiki F., Kuligovski C., Olandoski M., Moutinho J. A., Dallagiovanna B., Goldenberg S., Brofman P. S., Nakao L. S., Correa A., Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochemical and Biophysical Research Communications 2009 378 3 456 461 2-s2.0-57749171376 10.1016/j.bbrc.2008.11.061
8. Xu W., Zhang X., Qian H., Zhu W., Sun X., Hu J., Zhou H., Chen Y., Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Experimental Biology and Medicine 2004 229 7 623 631 2-s2.0-3042856796 (Pubitemid 38878907)
9. Kim D. H., Park S. J., Kim J. M., Jeon S. J., Kim D. H., Cho Y. W., Son K. H., Lee H. J., Moon J. H., Cheong J. H., Ko K. H., Ryu J. H., Cognitive dysfunctions induced by a cholinergic blockade and A β 25-35 peptide are attenuated by salvianolic acid B. Neuropharmacology 2011 61 8 1432 1440 2-s2.0-80053586194 10.1016/j.neuropharm.2011.08.038
10. Isacchi B., Fabbri V., Galeotti N., Bergonzi M. C., Karioti A., Ghelardini C., Vannucchi M. G., Bilia A. R., Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. European Journal of Pharmaceutical Sciences 2011 44 4 552 558 2-s2.0-80455167963 10.1016/j.ejps.2011.09.019
11. Chen T., Liu W., Chao X., Zhang L., Qu Y., Huo J., Fei Z., Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Research Bulletin 2011 84 2 163 168 2-s2.0-79451471769 10.1016/j.brainresbull.2010.11.015
12. Xu L., Deng Y., Feng L., Li D., Chen X., Ma C., Liu X., Yin J., Yang M., Teng F., Wu W., Guan S., Jiang B., Guo D., Cardio-protection of salvianolic acid b through inhibition of apoptosis network. PLoS ONE 2011 6 9 2-s2.0-80052446160 10.1371/journal.pone.0024036 e24036
13. Schittini A. V., Celedon P. F., Stimamiglio M. A., Krieger M., Hansen P., Da Costa F. D. A., Goldenberg S., Dallagiovanna B., Correa A., Human cardiac explant-conditioned medium: Soluble factors and cardiomyogenic effect on mesenchymal stem cells. Experimental Biology and Medicine 2010 235 8 1015 1024 2-s2.0-77955689709 10.1258/ebm.2010.010003
14. Brade T., Männer J., Kühl M., The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovascular Research 2006 72 2 198 209 2-s2.0-33749435799 10.1016/j.cardiores.2006.06.025 (Pubitemid 44511910)
15. Korkaya H., Paulson A., Charafe-Jauffret E., Ginestier C., Brown M., Dutcher J., Clouthier S. G., Wicha M. S., Regulation of mammary stem/progenitor cells by PTEN/Akt/ β -catenin signaling. PLoS Biology 2009 7 6 2-s2.0-67649969473 10.1371/journal.pbio.1000121 e1000121
16. Staal Frank J. T., Sen J. M., The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. European Journal of Immunology 2008 38 7 1788 1794 2-s2.0-50549083083 10.1002/eji.200738118
17. Pu P., Zhang Z., Kang C., Jiang R., Jia Z., Wang G., Jiang H., Downregulation of Wnt2 and β -catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Therapy 2009 16 4 351 361 2-s2.0-62549151288 10.1038/cgt.2008.78
18. Naito A. T., Shiojima I., Akazawa H., Hidaka K., Morisaki T., Kikuchi A., Komuro I., Developmental stage-specific biphasic roles of Wnt/ β -catenin signaling in cardiomyogenesis and hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 52 19812 19817 2-s2.0-33845928762 10.1073/pnas.0605768103 (Pubitemid 46037513)
19. Cohen E. D., Tian Y., Morrisey E. E., Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 2008 135 5 789 798 2-s2.0-42149159492 10.1242/dev.016865 (Pubitemid 351524132)
20. Bergmann M. W., WNT signaling in adult cardiac hypertrophy and remodeling: Lessons learned from cardiac development. Circulation Research 2010 107 10 1198 1208 2-s2.0-78549292104 10.1161/CIRCRESAHA.110.223768
21. Cho J., Rameshwar P., Sadoshima J., Distinct roles of glycogen synthase kinase (GSK)-3 α and GSK-3 β in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. Journal of Biological Chemistry 2009 284 52 36647 36658 2-s2.0-73649104072 10.1074/jbc.M109.019109
22. Wakitani S., Saito T., Caplan A. I., Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle and Nerve 1995 18 12 1417 1426 2-s2.0-0028788268 10.1002/mus.880181212
23. Wei F., Wang T., Liu J., Du Y., Ma A., The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Experimental Cell Research 2011 317 18 2661 2670 2-s2.0-80053617123 10.1016/j.yexcr.2011.08.011
24. Dell'Ovo V., Bandi E., Coslovich T., Florio C., Sciancalepore M., Decorti G., Sosa S., Lorenzon P., Yasumoto T., Tubaro A., In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes. Toxicological Sciences 2008 106 2 392 399 2-s2.0-56649100789 10.1093/toxsci/kfn187
25. Zhang F. B., Li L., Fang B., Zhu D. L., Yang H. T., Gao P. J., Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells. Biochemical and Biophysical Research Communications 2005 336 3 784 792 2-s2.0-25144507194 10.1016/j.bbrc.2005.08.177 (Pubitemid 41338337)
26. Liu Y., Song J., Liu W., Wan Y., Chen X., Hu C., Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovascular Research 2003 58 2 460 468 2-s2.0-0038030816 10.1016/S0008-6363(03)00265-7 (Pubitemid 36570404)
27. Pan C., Lou L., Huo Y., Singh G., Chen M., Zhang D., Wu A., Zhao M., Wang S., Li J., Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by no production through multiple pathways. Therapeutic Advances in Cardiovascular Disease 2011 5 2 99 111 2-s2.0-79956024633 10.1177/1753944710396538
28. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
29. Cho J., Zhai P., Maejima Y., Sadoshima J., Myocardial injection with GSK-3 β -overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circulation Research 2011 108 4 478 489 2-s2.0-79952068625 10.1161/CIRCRESAHA.110.229658
30. Mirotsou M., Zhang Z., Deb A., Zhang L., Gnecchi M., Noiseux N., Mu H., Pachori A., Dzau V., Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America 2007 104 5 1643 1648 2-s2.0-33846845067 10.1073/pnas.0610024104 (Pubitemid 46214644)
31. Alfaro M. P., Pagnia M., Vincent A., Atkinson J., Hill M. F., Cates J., Davidson J. M., Rottman J., Leed E., Young P. P., The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18366 18371 2-s2.0-57449109336 10.1073/pnas.0803437105
32. Willems E., Spiering S., Davidovics H., Lanier M., Xia Z., Dawson M., Cashman J., Mercola M., Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circulation Research 2011 109 4 360 364 2-s2.0-80051796581 10.1161/CIRCRESAHA. 111.249540
33. Egea V., Zahler S., Rieth N., Neth P., Popp T., Kehe K., Jochum M., Ries C., Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/ β -catenin signaling. Proceedings of the National Academy of Sciences of the United States of America 2012 109 6 309 316 2-s2.0-84857126923 10.1073/pnas.1115083109
34. Li H., Yu B., Zhang Y., Pan Z., Xu W., Li H., Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications 2006 341 2 320 325 2-s2.0-31444441172 10.1016/j.bbrc.2005.12.182 (Pubitemid 43152109)
35. He Z., Li H., Zuo S., Pasha Z., Wang Y., Yang Y., Jiang W., Ashraf M., Xu M., Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes. Stem Cells and Development 2011 20 10 1771 1778 2-s2.0-80052889729 10.1089/scd.2010.0380
36. Li H., Zuo S., Pasha Z., Yu B., He Z., Wang Y., Yang X., Ashraf M., Xu M., GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4. Cytotherapy 2011 13 9 1057 1065 2-s2.0-80052897930 10.3109/14653249.2011.597380